Sources: Otsuka prepares to go public

Japan's Otsuka Pharmaceutical plans to go public with a market capitalization of around $11 billion, reports Reuters, quoting sources close to the company. That will leave Otsuka behind Takeda, Astellas, and Daiichi Sankyo and even with Eisai. The Japanese pharma companies have been playing a growing role partnering with U.S. biotech companies in recent years. Report